Guangzhou Blood Center
Guangzhou, Guangdong, 510095, China
NCT Number: NCT03741387
Rh negative blood group is a rare blood group in China, as it only accounts for 0.3-0.4 percent of the Han population. Therefore, low inventory is often found in blood collection and supply agencies in many regions in China. In order to assess the effects of the gain-versus-loss framing message on blood donation among Rh negative donors, we designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the questions which survey the attitude of saving patients lives, and the other was to survey the attitude of preventing patients from death. The questionnaires were randomly sent to Rh negative blood donors.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510095, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Questionnaires focusing on the attitude of saving patients' lives were given to Rh negative blood donors in this group.
Questionnaires focusing on the attitude of preventing patients from death were given to Rh negative blood donors in this group.
Time frame: 1 day
After participants view the picture in their questionnaires, they would answer the questions about attitude of saving patients' lives or preventing patients from death.
Guangzhou Blood Center
Other Gov
Saving a Life or Preventing a Death: the Effect of Message Framing on Blood Donation Among Rh Negative Donors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03741413
Rh Negative Blood Donor
Guangzhou, Guangdong, China
View Trial Details